Central AsianResearch Index

Coronavirus infection sars-cov-2(covid-19) in patients with type 2 diabetes mellitus and the effect of glucose-lowering therapy on disease outcomes

Течение коронавирусной инфекции Sars-cov-2 (ковид-19) у пациентов с сахарным диабетом 2 типа и влияние сахароснижающей терапии на исходы заболевания

Underlying diabetes mellitus type 2 are considered risk factor for increased coronavirus disease (COVID-19) disease severity and worse outcomes, including higher mortality, respiratory failure, thromboembolic complications.In this regard, it is relevant to study the factors influencing the unfavorable outcomes of the course of Covid-19 in diabetes mellitus type 2. The most important task is to organize the management of diabetes mellitus during the period of coronavirus infection and the choice of safe and effective glucose-lowering therapy. This article analyzes the impact of previous and current glucose-lowering therapy on the outcomes of coronavirus infection in patients with diabetes mellitus type 2 based on published research results

Сведения

Опубликовано
2022 · С. 37-45
Язык
Английский
ISSN
1562-2940 · 2790-1203
Издатель
NpJSC "Astana Medical University